Your session is about to expire
← Back to Search
Anticholinergic
experimental for Near-sightedness
Phase 3
Waitlist Available
Research Sponsored by The V.P. Vyhodcev Eye Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline - 12 months
Awards & highlights
Summary
This trial tests if using a small amount of atropine eye drops can slow down worsening eyesight in Russian children with nearsightedness. The study aims to see if this treatment is safe and effective without causing significant side effects. Researchers are particularly interested in whether it works as well in Russian children as it does in Asian children. Atropine eye drops at low concentrations have been shown to slow myopia progression in children in various studies, including those conducted in East Asia and the USA.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline - 12 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline - 12 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
change in axial length
change in myopic progression rate
Secondary outcome measures
change in difference between manifest and cycloplegic refractions
change in positive relative accommodation
tear production
Trial Design
1Treatment groups
Experimental Treatment
Group I: experimentalExperimental Treatment1 Intervention
0.01% Atropine Sulfate solution in "Comfort Drops", nightly instillations to both eyes
Find a Location
Who is running the clinical trial?
The V.P. Vyhodcev Eye HospitalLead Sponsor
Share this study with friends
Copy Link
Messenger